Last Updated: November 9, 2026

Drug Price Trends for TOPIRAMATE

« Back to Dashboard


Drug Price Trends for TOPIRAMATE

Average Pharmacy Cost for TOPIRAMATE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Glossary
Drug Name NDC Price/Unit ($) Unit Date
TOPIRAMATE 100 MG TABLET 82009-0137-05 0.05555 EACH 2026-07-22
TOPIRAMATE 50 MG TABLET 82009-0136-05 0.03359 EACH 2026-07-22
TOPIRAMATE 25 MG TABLET 82009-0135-05 0.02550 EACH 2026-07-22
TOPIRAMATE 200 MG TABLET 76282-0281-60 0.10825 EACH 2026-07-22
TOPIRAMATE 200 MG TABLET 76282-0281-10 0.10825 EACH 2026-07-22
TOPIRAMATE 100 MG TABLET 76282-0280-60 0.05555 EACH 2026-07-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Subscribe to access the full database, or Start Trial

Best Wholesale Price for TOPIRAMATE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
TROKENDI XR 200MG CAP Supernus Pharmaceuticals, Inc. 17772-0104-01 100 2821.97 28.21970 EACH 2024-01-01 - 2027-09-14 FSS
TROKENDI XR 50MG CAP Supernus Pharmaceuticals, Inc. 17772-0102-01 100 1041.21 10.41210 EACH 2024-01-01 - 2027-09-14 FSS
TROKENDI XR 100MG CAP Supernus Pharmaceuticals, Inc. 17772-0103-01 100 2073.16 20.73160 EACH 2023-03-01 - 2027-09-14 Big4
TROKENDI XR 25MG CAP Supernus Pharmaceuticals, Inc. 17772-0101-01 100 803.29 8.03290 EACH 2023-03-01 - 2027-09-14 Big4
TROKENDI XR 50MG CAP Supernus Pharmaceuticals, Inc. 17772-0102-01 100 1172.54 11.72540 EACH 2022-09-15 - 2027-09-14 FSS
TROKENDI XR 200MG CAP Supernus Pharmaceuticals, Inc. 17772-0104-01 100 3177.92 31.77920 EACH 2022-09-15 - 2027-09-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type

Subscribe to access the full database, or Start Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links